Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2005 Jun;64(6):962–964. doi: 10.1136/ard.2004.025882

Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

B Bodaghi, Q Bui, B Wechsler, T Tran, N Cassoux, Huong D Le Thi, O Chosidow, S Herson, J Piette, P LeHoang
PMCID: PMC1755514  PMID: 15897316

Full Text

The Full Text of this article is available as a PDF (81.1 KB).

Figure 1.

Figure 1

 Early relapse of posterior uveitis in a patient with Behçet's disease, 6 weeks after the third infusion of infliximab. Fluorescein angiography showing diffuse retinal choriocapillaropathy, macular oedema, and papillitis.


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES